BioCentury
ARTICLE | Company News

Metra deal

December 20, 1993 8:00 AM UTC

Metra's technology uses pyridinium crosslinks, which are markers specific to bone that are released into the blood and urine as a consequence of the bone resorption process. Metra's Pyrilinks and Pyri...